News Archive
Surprisingly, Kofi Essel, a fourth year medical student at The George Washington University School of Medicine and Health Sciences (SMHS), was able to sleep through the night, March 16.
Less than 24 hours after discovering where they will be continuing their medical education in residency, a group of fourth-year medical students at The George Washington University School of Medicine and Health Sciences (SMHS) was not quite ready to say goodbye to medical school until they had…
Despite the popularity of health applications, or "apps," for mobile phones, there has been little research on how well apps work, or if they comply with known public health guidelines on how to change people's behaviors.
The hair-growth drug finasteride, commonly marketed under the trademark name Propecia, can cause persistent sexual dysfunction well after a patient stops taking the medication, according to a study by Michael Irwig, M.D., assistant professor of Medicine in the School of Medicine and Health…
A new study by The George Washington University School of Medicine and Health Sciences, which will be published in The Journal of Sexual Medicine, suggests men who take the drug finasteride, commonly marketed under the trademark names Propecia and Proscar, may report an on-going reduction in sex…
Scientists say the amount of radioactivity from Japan should pose no danger to people living in the United States.
Some people tell Congresswoman Debbie Wasserman Schultz (D-FL) that she is lucky to be alive. But Wasserman Schultz, who battled a particularly lethal type of breast cancer, attributes her survival to more than luck.
Washington (March 11, 2011) – Washington, D.C., Mayor Vincent Gray has appointed Jeffrey S. Akman, M.D., to serve on the newly created Mayor’s Commission on HIV/AIDS.
Proteins in fluids bathing the brain are essential for building the brain, discover scientists in a report published March 10 in the journal Neuron. The finding promises to advance research related to neurological disease, cancer, and stem cells.
Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all.